Product logins

Find logins to all Clarivate products below.


Pain Management Devices | Market Insights | Europe (Supplemental) | 2023

The COVID-19 pandemic significantly impacted the pain management device market because the associated procedures are considered nonurgent and pain will be managed using alternate therapies hindering the rebound of procedure volumes to some extent. However, as the situation around COVID-19 stabilizes, there will be increasing adoption of innovative and premium-priced products that will lead to moderate growth in European pain management device market over the forecast period.

This Medtech 360 Report provides high-level market metrics for pain management devices in Europe, including country-level data for major countries and aggregate data for the rest of the European region from 2019 through 2031.

Related Medtech Insights Reports

Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Europe
The European EP mapping and ablation device market will grow moderately through 2035, driven by the rising prevalence of cardiac arrhythmias, improved access to treatment, advancements in ablation…
Report
Aortic Repair Devices – Market Insights – Europe
The European aortic stent graft market is the primary driver of growth in the aortic repair device market and will drive revenue expansion over the forecast period, supported by ongoing innovation…
Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for moderate growth over the forecast period, driven by increasing PCI volumes for complex CAD cases and the…
Report
Dental Implants – Market Insights – Europe
The European dental implant market is projected to experience modest expansion through 2035. Growth is driven by an aging population with ongoing long-term restorative needs, a persistent burden of…
Report
Diabetes Care Devices – Market Insights – Europe
The European diabetes care device market will grow moderately over the forecast period, driven by a rising diabetes population, favorable reimbursement policies, ongoing device innovation, and the…